Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Short Interest Up 8.1% in June

Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily trading volume, of 3,360,000 […]

Related Keywords

,Group One Trading ,Nasdaq ,Aridis Pharmaceuticals Price Performance ,Aridis Pharmaceuticals Company Profile ,Aridis Pharmaceuticals ,Vanguard Group Inc ,Commonwealth Equity Services ,Sabby Management ,News Ratings For Aridis Pharmaceuticals Daily ,Aridis Pharmaceuticals Inc ,Get Free Report ,Street Corp ,Equity Services ,Vanguard Group ,Aridis Pharmaceuticals Daily ,Nasdaq Ards ,Cards ,Medical ,Stocks ,Options ,Put ,Call ,